Bicara Therapeutics Ratios (2023-2026) | BCAX

Ratios Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Efficiency
Assets Average (Quarter) 517.08M494.04M465.83M439.14M427.84M492.30M
Equity Average (Quarter) -142.94M-154.42M-167.43M167.39M500.71M475.42M447.08M418.99M402.12M457.70M
Invested Capital (Quarter) -137.11M-148.77M-160.08M-174.78M509.56M491.88M458.96M435.20M402.78M401.45M513.96M
Leverage & Solvency
Equity Ratio (Quarter) -0.640.970.960.960.960.950.930.93
Valuation
Enterprise Value (Quarter) -230.44M-520.80M-489.71M-462.10M-436.61M-290.17M-414.80M-539.75M
Return Ratios
Return on Capital Employed (Quarter) -16.51%-22.91%-26.99%-33.75%-39.01%-38.43%
Return on Invested Capital (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%